Guidelines for using antiretroviral agents among HIV-infected adults and adolescents: The panel on clinical practices for treatment of HIV

Medicine & Life Sciences

• Anti-Retroviral Agents 100%
• HIV 49%
• Guidelines 45%
• Therapeutics 11%
• CD4 Lymphocyte Count 7%
• Virus Diseases 5%
• RNA 5%
• Viral Load 4%
• T-Lymphocytes 4%
• Drug Resistance 4%
• Risk Assessment 4%
• Pharmaceutical Preparations 4%
• United States Dept. of Health and Human Services 3%
• R Factors 3%
• Information Services 3%
• Patient Participation 2%
• Patient Education 2%
• Centers for Disease Control and Prevention (U.S.) 2%
• Reverse Transcriptase Polymerase Chain Reaction 2%
• Counseling 2%
• Acquired Immunodeficiency Syndrome 2%
• Disease Progression 2%
• History 1%
• Viruses 1%
• Clinical Trials 1%
• Quality of Life 1%
• Education 1%
• Morbidity 1%
• DNA 1%
• Mortality 1%